Treatment of men with rising prostate-specific antigen levels following radical prostatectomy.

@article{Tzou2011TreatmentOM,
  title={Treatment of men with rising prostate-specific antigen levels following radical prostatectomy.},
  author={Katherine S. Tzou and Winston W. Tan and Steven W. Buskirk},
  journal={Expert review of anticancer therapy},
  year={2011},
  volume={11 1},
  pages={125-36}
}
Approximately one-third of patients who undergo radical prostatectomy for prostate cancer will develop a detectable prostate-specific antigen (PSA) level within 10 years. Biochemical recurrence of disease is defined as a rising PSA level in the absence of clinical or radiographic evidence of disease. Management of PSA recurrence is controversial, as prostate cancer may take an indolent course, or it may aggressively develop into metastatic disease. The only potentially curative treatment for… CONTINUE READING